Nuwellis, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Jaramillo Nestor Jr., was filed 16 Mar 2023.
Nuwellis, Inc.: what insiders have been doing
This page follows insider dealings at Nuwellis, Inc. as filed with SEC (Form 4), a company from the Health Care sector. Nothing new has been filed by managers of Nuwellis, Inc. in twelve months, the latest record being from 11 June 2025.
Our records for Nuwellis, Inc. go back to 2012, with 49 purchases and 8 sales on the open market in total. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 8.3 m USD and net income at -17.5 m USD.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -90.9%Entry US$247,474.50 · Close at T+365 US$22,638.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 7,522 shares@ US$0.060.2% of flowCommon StockSEC:0001213867-25-000003:1
- 1,092,500 shares@ US$0.06100.0% of flowCommon StockSEC:0001213867-25-000003:0
- 4,098 shares@ US$4.79100.0% of flowCommon StockSEC:0001777051-23-000002:0Canonical exit: 13 Jun 2023 (T+90)
- 9,523 shares@ US$5.2530.7% of flowCommon StockSEC:0001596771-19-000017:0Canonical exit: 10 Jun 2019 (T+90)
- 72 shares@ US$1.03100.0% of flowCommon StockSEC:0001596771-18-000088:0
- 23,584 shares@ US$2.1229.6% of flowCommon StockSEC:0001140361-18-031727:0Canonical exit: 1 Oct 2018 (T+90)
- 30,141 shares@ US$0.486.2% of flowCommon StockSEC:0001144204-17-052491:1Canonical exit: 10 Jan 2018 (T+90)
- 31,504 shares@ US$0.567.6% of flowCommon StockSEC:0001144204-17-052491:0Canonical exit: 9 Jan 2018 (T+90)
- 78,211 shares@ US$0.6421.5% of flowCommon StockSEC:0001144204-17-048880:0Canonical exit: 12 Dec 2017 (T+90)
- 180,000 shares@ US$0.7861.0% of flowCommon StockSEC:0001144204-17-043745:0Canonical exit: 6 Nov 2017 (T+90)
- 13,253 shares@ US$0.643.7% of flowCommon StockSEC:0001144204-17-043745:1Canonical exit: 8 Nov 2017 (T+90)
- 100,000 sharesCommon StockSEC:0001596771-17-000033:0Canonical exit: 18 Jul 2017 (T+90)
- 1,437 shares0Common StockSEC:0001596771-17-000018:0
- 1,437 shares0Common StockSEC:0001596771-17-000009:0
- 1 shares@ US$52.80Common StockSEC:0001596771-17-000006:0
- 20 shares@ US$5.270.9% of flowCommon StockSEC:0001596771-17-000006:1
- 54 shares@ US$8.193.8% of flowCommon StockSEC:0001596771-17-000003:0
- 41 shares@ US$8.193.8% of flowCommon StockSEC:0001596771-17-000004:0
- 1,256 shares@ US$0.476.7% of flowCommon StockSEC:0001596771-16-000174:0
- 1,629 shares@ US$0.476.6% of flowCommon StockSEC:0001596771-16-000173:0
- 80,000 shares@ US$0.21969.4% of flowCommon StockSEC:0001596771-16-000165:0Canonical exit: 26 Feb 2017 (T+90)
- 1,256 shares@ US$0.182.5% of flowCommon StockSEC:0001596771-16-000164:0
- 1,629 shares@ US$0.182.5% of flowCommon StockSEC:0001596771-16-000163:0
- 1,629 shares@ US$0.375.0% of flowCommon StockSEC:0001596771-16-000160:0
- 1,256 shares@ US$0.375.0% of flowCommon StockSEC:0001596771-16-000161:0
25 of 223 declarations
About Nuwellis, Inc.
Nuwellis, Inc. is a company focused on developing innovative medical solutions for the treatment of edema. It is listed on the NASDAQ under the ticker symbol NUWE.
